. in the overwhelming number of cases the primary mutaOur review centers on the question of how the deregution targets a single signal transduction pathway. A story lation of ␤-catenin leads to malignant development in has rapidly unfolded in which the Wnt signaling pathway the mammalian gut epithelium. In focus will be the funcplays a central role in the etiology of this cancer. The tion of APC, still poorly understood at the molecular sequence of discoveries provides a classic example of level. We shall present new insights into how APC conthe synergy between insights gained from genetic studtrols ␤-catenin. We shall also summarize recent eviies of model organisms and cancer biology in man.
Figure 1. The Canonical Wnt Pathway
Activators of the pathway are white; negative regulators are gray. Left, in the absence of Wnt stimulation, the Axin complex actively earmarks ␤-catenin/Armadillo (white circles) for degradation by the proteasome. The levels of cytoplasmic ␤-catenin/Armadillo are low, and TCF is repressed. Right, after Wnt stimulation of the Frizzled receptor (arbitrarily drawn to be in the apical membrane), Dsh is recruited to the membrane where it binds to Axin to inhibit the Axin complex. ␤-catenin/ Armadillo accumulates and, after translocation into the nucleus, binds to TCF to coactivate Wnt target genes. Inhibition of the Axin complex by GBP/Frat appears to be an alternative to Wnt-mediated inhibition. CBP switches from being a negative regulator to being a coactivator, apparently depending on the stimulation status of the cell. Note also the apicolateral adherens junctions to which the Axin complex appears to be anchored. These junctions are formed by the transmembrane protein E-cadherin (black bars) which is linked to the actin cytoskeleton (thin lines) by ␤-catenin/Armadillo and ␣-catenin (black dots). Figure 4) . Intriguingly, overexmutant tumors. These cells also show high levels of pression of N-terminal truncations of ␤-catenin that bind nuclear ␤-catenin, and these can only be reduced effimore stably to APC than wild-type ␤-catenin impairs the ciently by exogenous APC which retain a minimum of migratory properties of these cells (Barth et al., 1997) . two NESs. It thus appears that the truncated APC typically observed in colon cancers may be unable to export
When cells are stimulated by Wnt ligands, the cytoby virtue of an intrinsic ability that does not depend on the Ran/importin machinery (Fagotto et al., 1998; plasmic protein Dishevelled is recruited to the membrane (Axelrod et al., 1998; Boutros et al., 2000). DishevYokoya et al., 1999). Once in the nucleus, ␤-catenin/ Armadillo binds to TCF (T cell factor) proteins and serves elled appears to inhibit the
Nelson and colleagues have argued that this is a conse-quence of the dynamics of APC-␤-catenin interaction; the high nuclear ␤-catenin levels that result from this it is conceivable that these APC "superbinders" may putative shift in equilibrium between the two ␤-catenin exert dominant-negative effects on the shuttling of norpools which may be due to APC loss. mal ␤-catenin by APC. Finally, it was discovered recently In summary, as initially suggested (e.g., Hü lsken et that APC binds to Asef, an exchange factor that apparal., 1994), APC could operate to suppress tumorigenesis ently activates the small G protein Rac which in turn at the level of cell migration and adhesion. Both of these controls the actin cytoskeleton (Kawasaki et al., 2000) . processes might be affected by mutant forms of ␤-catEvidence based on overexpression of exogenous proenin that interfere with the interaction between APC and teins suggested that APC activates Asef at the memnormal ␤-catenin (see above), but perhaps not by ␤-catbrane periphery and, as a consequence, induces cell enins with point mutations such as those found in canflattening and membrane ruffling, both signs of migracers. Thus, although the latter appear to be as potent tory activity. This is perhaps the most persuasive evias APC loss regarding transcriptional activation ( 
